Iron Toxicity in Emergency Medicine Workup
- Author: Clifford S Spanierman, MD; Chief Editor: Asim Tarabar, MD more...
Laboratory Studies
- Measure steady-state serum iron levels at least 4 hours postingestion. levels drawn more than 6 hours after ingestion may underestimate toxicity caused by ferritin binding and redistribution of iron.
- Mild-to-moderate toxicity generally manifests at levels of 350-500 mcg/dL.
- Hepatotoxicity usually is observed at levels higher than 500 mcg/dL.
- levels higher than 800 mcg/dL are associated with severe toxicity.
- Samples drawn too early or too late postingestion may be unreliable.
- In adults, hyperglycemia, leukocytosis, abdominal pain, and vomiting may be absent.
- Glucose levels
- Glucose levels exceeding 150 mg/dL are common with severe iron toxicity.
- Following glucose levels is important because hepatic dysfunction may cause hypoglycemia.
- Complete blood count
- A white blood cell (WBC) count more than 15,000/mm3 is associated with severe iron poisoning.
- A CBC is also helpful because anemia from blood loss may develop.
- In addition to serum lactic acid levels (lactate), the arterial blood gas (ABG) measurements are useful in determining the existence and severity of a metabolic acidosis.
- Coagulation studies are essential. Monitoring the prothrombin time may be helpful.
- Perform liver function tests (LFTs). Hepatic dysfunction is common in severe iron poisoning because the liver is the first organ outside of the GI tract to encounter large iron load through the portal blood supply.
- Electrolyte measurements and renal function tests assist in calculation of the anion gap and detection of electrolyte abnormalities and the presence of prerenal azotemia.
- Lipase and amylase levels may document occasional pancreatic injury.
- Obtain a pregnancy test in women of childbearing age.
- Determine type and cross-matching.
- Ferritin levels are helpful for chronic toxicity >1000 mcg/L.
- Iron toxicity is one of the MUDPILES (M-methanol; U-uremia; D-DKA, AKA; P-paraldehyde, phenformin; I-iron, isoniazid; L-lactic [ie, CO, cyanide]; E-ethylene glycol; S-salicylates) that causes an acidosis with an increased anion gap.
Imaging Studies
- A kidneys, ureters, bladder (KUB) film can determine if radiopacities are present; iron tablets are radiopaque for a few hours postingestion. However, the absence of radiopacities does not rule out a significant or lethal ingestion.
Morse SB, Hardwick WE Jr, King WD. Fatal iron intoxication in an infant. South Med J. Oct 1997;90(10):1043-7. [Medline].
Griffith EA, Fallgatter KC, Tantama SS, Tanen DA, Matteucci MJ. Effect of deferasirox on iron absorption in a randomized, placebo-controlled, crossover study in a human model of acute supratherapeutic iron ingestion. Ann Emerg Med. Jul 2011;58(1):69-73. [Medline].
Carlsson M, Cortes D, Jepson S, Kansstrup T. Severe iron intoxication treated with exchange transfusion. Arch Dis Child. April 2008;93(4):321-2. [Medline].
Ng HW, Tse ML, Lau FL, Chu W. Endoscopic removal of iron bezoar following acute overdose. Clin Toxicol (Phila). Nov 2008;46(9):913-5. [Medline].
Haider F, De Carli C, Dhanani S, Sweeny B. Emergency laparoscopic-assisted gastrotomy for the treatment of an iron bezoar. J Laparoendosc Adv Surg Tech A. April 2009;19 Suppl 1:S141-3. [Medline].
Cerezo A, Costan G Gonzale A, Galvez C , Garcia V, Iglesias E, Reye A, et al. Severe esophagitis due to overload of iron tablets. Gastroenterol Hepatol. Oct 2008;31(8):551-2. [Medline].
Valentine K, Mastropietro C, Sarnaik AP. Infantile iron poisonings: challenges in diagnosis and management. Pediatr Crit Care Med. May 2009;10 (3):e31-33. [Medline].
Alymara V, Bourantas D, Chaidos A. Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone. Hematol J. 2004;5(6):475-9. [Medline].
Atiq M, Dang S, Olden KW, Aduli F. Early endoscopic gastric lavage for acute iron overdose: a novel approach to accidental pill ingestions. Acta Gastroenterol Belg. Jul-Sep 2008;71(3):345-6. [Medline].
Bosse GM. Conservative management of patients with moderately elevated serum iron levels. J Toxicol Clin Toxicol. 1995;33(2):135-40. [Medline].
Cheney K, Gumbiner C, Benson B, Tenenbein M. Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine. J Toxicol Clin Toxicol. 1995;33(1):61-6. [Medline].
Goldberg sl. Novel treatment options for transfusional iron overload in patients with myleodysplatic syndromes. Leuk Res. Dec 2007;31:s16-22. [Medline].
Hershko CM, Link GM, Konijn AM. Iron chelation therapy. Curr Hematol Rep. Mar 2005;4(2):110-6. [Medline].
McGuigan MA. Acute iron poisoning. Pediatr Ann. Jan 1996;25(1):33-8. [Medline].
Mills KC, Curry SC. Acute iron poisoning. Emerg Med Clin North Am. May 1994;12(2):397-413. [Medline].
Palatnick W, Tenenbein M. Leukocytosis, hyperglycemia, vomiting, and positive X-rays are not indicators of severity of iron overdose in adults. Am J Emerg Med. Sep 1996;14(5):454-5. [Medline].
Tenenbein M. Benefits of parenteral deferoxamine for acute iron poisoning. J Toxicol Clin Toxicol. 1996;34(5):485-9. [Medline].

